< Back to latest news & events

Event

IAM IP & Emerging Technology Europe

March 2024

Event date: 6th March 2024

HGF are delighted to be Gold sponsors of the IP & Emerging Technology Europe event, due to take place on the 6th March in London

The event will be held in Cavendish Square, London where HGF Partner Matt Cassie will be moderating the panel session ‘New verticals and opportunities.’

The session will cover the emergence of new technologies – and the uptake of existing technologies by new sectors – and how this presents new opportunities for IP deal-making. The session will also explore:

  • Zooming in on IP opportunities for IoT and video codec
  • How best to capitalise on new licensing opportunities
  • Getting deals done in unfamiliar sectors

Click the button below to find out more.

FIND OUT MORE

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates